MIR8087

Across TCGA pan-cancer cohorts, MIR8087 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of MIR8087’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where MIR8087 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR8087 is over-expressed in tumor, although a few such as THCA and KIRP show the opposite, repressed pattern.

THCA, LUSC, and LUAD are the cancer types where MIR8087 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR8087 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	−0.255	.003	5	view →
LUSC	Male	All	+0.403	.002	4	view →
LUAD	Male	All	+0.430	.028	2	view →
LIHC	Male	All	+0.170	.023	2	view →
KIRP	All	All	−0.262	.014	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

MIR8087–THCA

Open the THCA breakdown →